Table 4.
TREATMENT RECOMMENDATIONS FOR PREVENTION OF IDIOPATHIC CALCIUM STONES IN ADULTS
| Treatment | Mechanism of action | Doses | Selection criteria | Potential complications |
|---|---|---|---|---|
| Fluids | Lowers supersturation by dilution of solutes | Adequate to maintain urine volume > 2 liters daily. | Useful for all SF. May be used as sole treatment for patients with a single stone episode. | Avoid fluids containing excess salt or carbohydrates |
| Diet | Lowers supersaturation by decreasing calcium and oxalate excretion | Na < 100 mmol/day Protein < 0.8–1 gm animal protein/kg BW | Especially useful for hypercalciuric or hyperuricosuric SF. | May be hard to maintain |
| Oxalate < 100 mg/day | Hyperoxaluric SF | May be hard to maintain | ||
| Maintains bone mineral, prevents hyperoxaluria | Calcium 800–1000 mg/day | All calcium SF | Should obtain from dietary sources, avoid supplements | |
| Thiazide-type diuretics | Lowers supersaturation by decreasing calcium excretion | Chlorthalidone 12.5–50 mg daily Indapamide 1.25–2.5 daily Hydrochlorothiazide 12.5–25 mg twice daily | Hypercalciuric SF, may be useful for some normocalciuric SF | Hypokalemia, lowers blood pressure (may be desirable), allergy and sun sensitivity |
| Potassium alkali | Lowers supersaturation by chelating calcium Inhibits calcium crystal growth | Potassium citrate 10–20 meq bid-tid | Hypocitraturic SF | Monitor urine pH and CaP SS, avoid SS > 1 |
| Allopurinol | Lowers urine uric acid concentration, which may improve solubility of calcium salts | 100–300 mg/day (may be taken once daily) | Hyperuricosuric calcium SF | Allergy, may be severe. |